140 related articles for article (PubMed ID: 35580545)
21. Studying KCNQ1 Mutation and Drug Response in Type 1 Long QT Syndrome Using Patient-Specific Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Wei H; Wu J; Liu Z
Methods Mol Biol; 2018; 1684():7-28. PubMed ID: 29058180
[TBL] [Abstract][Full Text] [Related]
22. Microscopic mechanisms for long QT syndrome type 1 revealed by single-channel analysis of I(Ks) with S3 domain mutations in KCNQ1.
Eldstrom J; Wang Z; Werry D; Wong N; Fedida D
Heart Rhythm; 2015 Feb; 12(2):386-94. PubMed ID: 25444851
[TBL] [Abstract][Full Text] [Related]
23. Impaired ion channel function related to a common KCNQ1 mutation - implications for risk stratification in long QT syndrome 1.
Aidery P; Kisselbach J; Schweizer PA; Becker R; Katus HA; Thomas D
Gene; 2012 Dec; 511(1):26-33. PubMed ID: 23000022
[TBL] [Abstract][Full Text] [Related]
24. Abnormal KCNQ1 trafficking influences disease pathogenesis in hereditary long QT syndromes (LQT1).
Wilson AJ; Quinn KV; Graves FM; Bitner-Glindzicz M; Tinker A
Cardiovasc Res; 2005 Aug; 67(3):476-86. PubMed ID: 15935335
[TBL] [Abstract][Full Text] [Related]
25. Human Induced Pluripotent Stem Cell-Derived Engineered Heart Tissue as a Sensitive Test System for QT Prolongation and Arrhythmic Triggers.
Lemoine MD; Krause T; Koivumäki JT; Prondzynski M; Schulze ML; Girdauskas E; Willems S; Hansen A; Eschenhagen T; Christ T
Circ Arrhythm Electrophysiol; 2018 Jul; 11(7):e006035. PubMed ID: 29925535
[TBL] [Abstract][Full Text] [Related]
26. [Analysis of the KCNQ1 gene mutation in 2 families with congenital long QT syndrome type 1 in Xinjiang Uygur Autonomous Region].
Li YD; Maimaitiabudula M; Zhou XH; Lu YM; Zhang JH; Xing Q; Tang BP
Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Nov; 46(11):868-873. PubMed ID: 30462975
[No Abstract] [Full Text] [Related]
27. LQT1-associated mutations increase KCNQ1 proteasomal degradation independently of Derlin-1.
Peroz D; Dahimène S; Baró I; Loussouarn G; Mérot J
J Biol Chem; 2009 Feb; 284(8):5250-6. PubMed ID: 19114714
[TBL] [Abstract][Full Text] [Related]
28. Interactions between KCNQ1 and KCNH2 may modulate the long QT type 1 phenotype.
Odening KE
Cardiovasc Res; 2024 May; 120(7):673-674. PubMed ID: 38630861
[No Abstract] [Full Text] [Related]
29. Generation of the human induced pluripotent stem cell (hiPSC) line PSMi003-A from a patient affected by an autosomal recessive form of Long QT Syndrome type 1.
Mura M; Ginevrino M; Zappatore R; Pisano F; Boni M; Castelletti S; Crotti L; Valente EM; Schwartz PJ; Gnecchi M
Stem Cell Res; 2018 May; 29():170-173. PubMed ID: 29684900
[TBL] [Abstract][Full Text] [Related]
30. R231C mutation in KCNQ1 causes long QT syndrome type 1 and familial atrial fibrillation.
Bartos DC; Duchatelet S; Burgess DE; Klug D; Denjoy I; Peat R; Lupoglazoff JM; Fressart V; Berthet M; Ackerman MJ; January CT; Guicheney P; Delisle BP
Heart Rhythm; 2011 Jan; 8(1):48-55. PubMed ID: 20850564
[TBL] [Abstract][Full Text] [Related]
31. A KCNQ1 mutation contributes to the concealed type 1 long QT phenotype by limiting the Kv7.1 channel conformational changes associated with protein kinase A phosphorylation.
Bartos DC; Giudicessi JR; Tester DJ; Ackerman MJ; Ohno S; Horie M; Gollob MH; Burgess DE; Delisle BP
Heart Rhythm; 2014 Mar; 11(3):459-68. PubMed ID: 24269949
[TBL] [Abstract][Full Text] [Related]
32. Generation of an induced pluripotent stem cell line from patient with atrial fibrillation with KCNQ1 p.Ser209Pro mutation.
Cen Y; Zhou T; Chen S; Deng Z; Wang J; Ma N; Zhang S
Stem Cell Res; 2024 Apr; 76():103336. PubMed ID: 38341987
[TBL] [Abstract][Full Text] [Related]
33. A novel mutation KCNQ1p.Thr312del is responsible for long QT syndrome type 1.
Chen XM; Guo K; Li H; Lu QF; Yang C; Yu Y; Hou JW; Fei YD; Sun J; Wang J; Li YX; Li YG
Heart Vessels; 2019 Jan; 34(1):177-188. PubMed ID: 30008122
[TBL] [Abstract][Full Text] [Related]
34. NOS1AP polymorphisms reduce NOS1 activity and interact with prolonged repolarization in arrhythmogenesis.
Ronchi C; Bernardi J; Mura M; Stefanello M; Badone B; Rocchetti M; Crotti L; Brink P; Schwartz PJ; Gnecchi M; Zaza A
Cardiovasc Res; 2021 Jan; 117(2):472-483. PubMed ID: 32061134
[TBL] [Abstract][Full Text] [Related]
35. Pharmacogenomics of anesthetic drugs in transgenic LQT1 and LQT2 rabbits reveal genotype-specific differential effects on cardiac repolarization.
Odening KE; Hyder O; Chaves L; Schofield L; Brunner M; Kirk M; Zehender M; Peng X; Koren G
Am J Physiol Heart Circ Physiol; 2008 Dec; 295(6):H2264-72. PubMed ID: 18835916
[TBL] [Abstract][Full Text] [Related]
36. Dominant-negative I(Ks) suppression by KCNQ1-deltaF339 potassium channels linked to Romano-Ward syndrome.
Thomas D; Wimmer AB; Karle CA; Licka M; Alter M; Khalil M; Ulmer HE; Kathöfer S; Kiehn J; Katus HA; Schoels W; Koenen M; Zehelein J
Cardiovasc Res; 2005 Aug; 67(3):487-97. PubMed ID: 15950200
[TBL] [Abstract][Full Text] [Related]
37. In Vitro Drug Screening Using iPSC-Derived Cardiomyocytes of a Long QT-Syndrome Patient Carrying KCNQ1 & TRPM4 Dual Mutation: An Experimental Personalized Treatment.
Wang F; Han Y; Sang W; Wang L; Liang X; Wang L; Xing Q; Guo Y; Zhang J; Zhang L; Zukela T; Xiaokereti J; Lu Y; Zhou X; Tang B; Li Y
Cells; 2022 Aug; 11(16):. PubMed ID: 36010573
[TBL] [Abstract][Full Text] [Related]
38. shRNAs Targeting a Common
Cócera-Ortega L; Wilders R; Kamps SC; Fabrizi B; Huber I; van der Made I; van den Bout A; de Vries DK; Gepstein L; Verkerk AO; Pinto YM; Tijsen AJ
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409410
[TBL] [Abstract][Full Text] [Related]
39. Establishment of an iPSC line (JSPHi001-A) from a patient with familial dilated cardiomyopathy and atrial fibrillation caused by LMNA missense mutation (c.1003C > T).
Zhang Y; Zhu Y; Lin Y; Liu H; Chen H; Ju W; Cui C; Chen M
Stem Cell Res; 2021 May; 53():102349. PubMed ID: 33887581
[TBL] [Abstract][Full Text] [Related]
40. Dominant-negative control of cAMP-dependent IKs upregulation in human long-QT syndrome type 1.
Heijman J; Spätjens RL; Seyen SR; Lentink V; Kuijpers HJ; Boulet IR; de Windt LJ; David M; Volders PG
Circ Res; 2012 Jan; 110(2):211-9. PubMed ID: 22095730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
